A study on patients with breast carcinomas showed that both Breast-Specific Gamma Imaging and MRI had a 97% sensitivity in identifying malignancies. Eleven percent of the cancers detected with BSGI were in patients who had equivocal or negative mammograms, according to the study, which performed BSGI prior to needle biopsy. "BSGI proved to be a cost-effective breast diagnostic imaging modality, able to detect mammographically occult breast cancers and provide comparable sensitivity to MRI at a higher patient compliance rate and lower cost," an expert said.

Full Story:
PR Newswire

Related Summaries